Thursday, August 9, 2007

15 companies raise €66.7 million
More Details?

New profiles


Add your Profile

IBC Conference
RFID Europe
Fifth MedTech Investing Europe Conference

Submit your event(s)!

On the move

Phill Robinson joins CacheLogic as CEO

Career move?

Created by: Tornado Staff

German startups appeal to Europe’s venture capitalists

As venture capital activity slows down during the summer months, we take a closer look at how the 2007 deals have been distributed over the continent.

As usual the UK have secured most deals. 30.6% of all technology investments targeted UK companies - on par with the average for all deals since 2000. Germany is experiencing a relatively good year thus far raising 16.7% of all deals (13.6% since 2000) – placing it second in Europe. The country swapped ranks with France, which trails at 11% in 2007 – down considerably on its 7-year average of 14.1%. Israel remains fourth with 8.7% (8.1% since 2000), followed by The Netherlands (6.3% in 2007; 5.4% since 2000), Denmark (4.4% in 2007; 4.1% since 2000), and Sweden (4.1% in 2007; 6.4% since 2000). Ireland is showing poor performance this year as it ranked fourteenth with 1.4% of all deals in Europe – down 6 places and 2.5% on its 7-year average.

The ranking of cities over 2007 shows a huge lead for London. Technology companies in the English capital raised 8.2% of all European deals this year, just below London’s 7-year average of 8.8%. Second comes Paris with 4.4% of all deals, 1% lower than its average since 2000. Berlin is showing a lot of activity ranking third with 3.5% of all deals in 2007 – up 5 ranks and 1.8% on its 7-year average. The fourth place is for another German city, Munich, with 3.1% (ranked sixth with 2.7% for all deals since 2000). Losing out in 2007 are Cambridge (2.1% in 2007; 3.1% since 2000), Dublin (1.4% in 2007; 3.1% since 2000) and Stockholm (0.9% in 2007; 2.9% since 2000).

The distribution of venture capital deals per sector over the European cities often gives a strong indication of the technology strengths in the different regions. For instance, Cambridge leads the city ranks for Biotechnology & Healthcare funding since 2000 – 5.8% of all deals in Europe. Second is Munich with 4.3%, although the bulk of these deals were raised just outside the city in biotech hotspot Martinsried. Munich is followed by Paris (2.7%) and Copenhagen (2.5%). London tops the ranks for Software having secured 9.1% of the venture deals. Paris is ranked second with 6.4%, followed by Dublin (4.8%) and Amsterdam (2.7%). For Internet investments London is clearly the place to be as it has raised a whopping 20.8% of all European deals in the sector. Paris is popular destination for Internet funding as well with 10.7%. London is in the lead for Communications as well (9.1%), not surprisingly followed by Stockholm (6.5%). Computers & Electronics companies in Cambridge were most in favor among VCs with 4.3%. Noteworthy is that 4 Israeli cities are present in the top 10 for this sector, of which Herzliya follows Cambridge in second place (2.6%).

Payment Options in US Multiply Challenging PayPal Market Dominance
Another name change for Esprit as DSJ acquires stake
Mass pump-and-dump scam causes spam level surge
SAFE ID Solutions AG secures multi-million follow-up passport deal ...
Synchronica Launches Free Trial - Delivering Microsoft Exchange Email ...
Mirics closes $12M B round funding with investment from Acacia ...
T-systems Venture Fund invests in Litescape Technologies
PolyTherics and BioVectra dcl sign Manufacturing and Representation Deal
AM-Pharma announces 2.5 million EURO financing
LSP BioVentures leads $10 million Series C investment in BioProcessors
Sophos names Dirk Christiansen as Vice President of Global Marketing
Investment Success for MindWeavers augurs well for Admission to PLUS ...
Staffordshire Screening Programme on track to screen over 35,000 Diab ...
Peter Keen appointed to the Prelude Trust Board

Copyright © 2004-2014 Emerging Technology Research Europe Inc. All rights reserved.
Subscribe here. Unsubscribe here.